Differential impact of flavonoids on redox modulation, bioenergetics, and cell signaling in normal and tumor cells: A comprehensive review

Antioxidants and Redox Signaling

Volumn 29, Issue 16, 2018, Pages 1633-1659

  Kerimi, Asimina ^a   Williamson, Gary ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Cancer; Glucose; Hepatocyte; HepG2; Quercetin

Indexed keywords

EPICATECHIN; EPICATECHIN GALLATE; FLAVONOID; POLYPHENOL DERIVATIVE; QUERCETIN DERIVATIVE; TRANSCRIPTION FACTOR NRF2;

ARTICLE; BIOENERGY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; COMPARATIVE STUDY; DRUG EFFECT; ENERGY METABOLISM; HEP-G2 CELL LINE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTESTINE FLORA; INTESTINE TISSUE; LIPID METABOLISM; NEOPLASM; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PANCREAS CELL; PRIORITY JOURNAL; REDOX STRESS; SIGNAL TRANSDUCTION; TEA; TUMOR CELL; UPREGULATION; ANIMAL; CELL PROLIFERATION; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY;

ANIMALS; CELL PROLIFERATION; ENERGY METABOLISM; FLAVONOIDS; HUMANS; NEOPLASMS; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION;

EID: 85046381410     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2017.7086     Document Type: Article

References (283)

1. Actis-Goretta L, Leveques A, Giuffrida F, Romanov-Michailidis F, Viton F, Barron D, Duenas-Paton M, Gonzalez-Manzano S, Santos-Buelga C, Williamson G, and Dionisi F. Elucidation of (-)-epicatechin metabolites after ingestion of chocolate by healthy humans. Free Radic Biol Med 53: 787-795, 2012.
2. Adewole SO, Caxton-Martins EA, and Ojewole JA. Protective effect of quercetin on the morphology of pancreatic beta-cells of streptozotocin-treated diabetic rats. Afr J Tradit Complement Altern Med 4: 64-74, 2006.
3. Agullo G, Gamet L, Besson C, Demigne C, and Remesy C. Quercetin exerts a preferential cytotoxic effect on active dividing colon carcinoma HT29 and caco-2 cells. Cancer Lett 87: 55-63, 1994.
4. Ahlin G, Hilgendorf C, Karlsson J, Szigyarto CA, Uhlen M, and Artursson P. Endogenous gene and protein expression of drug-transporting proteins in cell lines routinely used in drug discovery programs. Drug Metab Dispos 37: 2275-2283, 2009.
5. Alam J, Stewart D, Touchard C, Boinapally S, Choi AMK, and Cook JL. Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem 274: 26071-26078, 1999.
6. Alia M, Ramos S, Mateos R, Granado-Serrano AB, Bravo L, and Goya L. Quercetin protects human hepatoma HepG2 against oxidative stress induced by tert-butyl hydroperoxide. Toxicol Appl Pharmacol 212: 110-118, 2006.
7. Amasheh M, Luettig J, Amasheh S, Zeitz M, Fromm M, and Schulzke JD. Effects of quercetin studied in colonic HT-29/B6 cells and rat intestine in vitro. Ann N Y Acad Sci 1258: 100-107, 2012.
8. Amin AR, Khuri FR, Chen ZG, and Shin DM. Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nuclear factor-kappaB. Cancer Prev Res (Phila) 2: 538-545, 2009.
9. An G, Wang X, and Morris ME. Flavonoids are inhibitors of human organic anion transporter 1 (OAT1)-mediated transport. Drug Metab Dispos 42: 1357-1366, 2014.
10. Angst E, Park JL, Moro A, Lu QY, Lu X, Li G, King J, Chen M, Reber HA, Go VL, Eibl G, and Hines OJ. The flavonoid quercetin inhibits pancreatic cancer growth in vitro and in vivo. Pancreas 42: 223-229, 2013.
11. Appari M, Babu KR, Kaczorowski A, Gross W, and Herr I. Sulforaphane, quercetin and catechins complement each other in elimination of advanced pancreatic cancer by miR-let-7 induction and K-ras inhibition. Int J Oncol 45: 1391-1400, 2014.
12. Awad HM, Boersma MG, Boeren S, van der Woude H, van Zanden J, van Bladeren PJ, Vervoort J, and Rietjens IM. Identification of o-quinone/quinone methide metabo-lites of quercetin in a cellular in vitro system. FEBS Lett 520: 30-34, 2002.
13. Bachmann M and Moroy T. The serine/threonine kinase Pim-1. Int J Biochem Cell Biol 37: 726-730, 2005.
14. Bacon JR, Williamson G, Garner RC, Lappin G, Langouet S, and Bao Y. Sulforaphane and quercetin modulate PhIP-DNA adduct formation in human HepG2 cells and hepa-tocytes. Carcinogenesis 24: 1903-1911, 2003.
15. Bardy G, Virsolvy A, Quignard JF, Ravier MA, Bertrand G, Dalle S, Cros G, Magous R, Richard S, and Oiry C. Quercetin induces insulin secretion by direct activation of L-type calcium channels in pancreatic beta cells. Br J Pharmacol 169: 1102-1113, 2013.
16. Barotto NN, Lopez CB, Eynard AR, Fernandez Zapico ME, and Valentich MA. Quercetin enhances pretumorous lesions in the NMU model of rat pancreatic carcinogen-esis. Cancer Lett 129: 1-6, 1998.
17. Belguise K, Guo S, Yang S, Rogers AE, Seldin DC, Sherr DH, and Sonenshein GE. Green tea polyphenols reverse cooperation between c-Rel and CK2 that induces the aryl hydrocarbon receptor, slug, and an invasive phenotype. Cancer Res 67: 11742-11750, 2007.
18. Bertram K, Valcu CM, Weitnauer M, Linne U, and Gor-lach A. NOX1 supports the metabolic remodeling of HepG2 cells. PLoS One 10: e0122002, 2015.
19. Blouin JM, Penot G, Collinet M, Nacfer M, Forest C, Laurent-Puig P, Coumoul X, Barouki R, Benelli C, and Bortoli S. Butyrate elicits a metabolic switch in human colon cancer cells by targeting the pyruvate dehydroge-nase complex. Int J Cancer 128: 2591-2601, 2011.
20. Boersma MG, van der Woude H, Bogaards J, Boeren S, Vervoort J, Cnubben NHP, van Iersel MLPS, van Bla-deren PJ, and Rietjens IMCM. Regioselectivity of phase 11 metabolism of luteolin and quercetin by UDP-glucuronosyl transferases. Chem Res Toxicol 15: 662-670, 2002.
21. Bonkovsky HL. Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). Ann Intern Med 144: 68-71, 2006.
22. Boots AW, Bast A, and Haenen GR. No role of DT-diaphorase (NQO1) in the protection against oxidized quercetin. FEBS Lett 579: 677-682, 2005.
23. Boots AW, Kubben N, Haenen GR, and Bast A. Oxidized quercetin reacts with thiols rather than with ascorbate: implication for quercetin supplementation. Biochem Bio-phys Res Commun 308: 560-565, 2003.
24. Boulton DW, Walle UK, and Walle T. Extensive binding of the bioflavonoid quercetin to human plasma proteins. J Pharm Pharmacol 50: 243-249, 1998.
25. Cairns RA, Harris I, McCracken S, and Mak TW. Cancer cell metabolism. Cold Spring Harb Symp Quant Biol 76: 299-311, 2011.
26. Cairns RA, Harris IS, and Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer 11: 85-95, 2011.
27. Camenisch G, Alsenz J, van de Waterbeemd H, and Folkers G. Estimation of permeability by passive diffusion through Caco-2cell monolayers using the drugs' lipophi-licity and molecular weight. Eur J Pharm Sci 6: 317-324, 1998.
28. Cano A, Arnao MB, Williamson G, and Garcia-Conesa MT. Superoxide scavenging by polyphenols: effect of conjugation and dimerization. Redox Report 7: 379-383, 2002.
29. Cao H, Pauff JM, and Hille R. X-ray crystal structure of a xanthine oxidase complex with the flavonoid inhibitor quercetin. J Nat Prod 77: 1693-1699, 2014.
30. Cao J, Han J, Xiao H, Qiao J, and Han M. Effect of tea polyphenol compounds on anticancer drugs in terms of anti-tumor activity, toxicology, and pharmacokinetics. Nutrients 8: 762, 2016.
31. Caro P, Kishan AU, Norberg E, Stanley IA, Chapuy B, Ficarro SB, Polak K, Tondera D, Gounarides J, Yin H, Zhou F, Green MR, Chen L, Monti S, Marto JA, Shipp MA, and Danial NN. Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma. Cancer Cell 22: 547-560, 2012.
32. Carracedo A, Cantley LC, and Pandolfi PP. Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer 13: 227-232, 2013.
33. Carrasco-Pozo C, Tan KN, Reyes-Farias M, De La Jara N, Ngo ST, Garcia-Diaz DF, Llanos P, Cires MJ, and Borges K. The deleterious effect of cholesterol and protection by quercetin on mitochondrial bioenergetics of pancreatic beta-cells, glycemic control and inflammation: in vitro and in vivo studies. Redox Biol 9: 229-243, 2016.
34. Carvalho KM, Morais TC, de Melo TS, de Castro Brito GA, de Andrade GM, Rao VS, and Santos FA. The natural flavonoid quercetin ameliorates cerulein-induced acute pancreatitis in mice. Biol Pharm Bull 33: 1534-1539, 2010.
35. Chandrasekaran K, Swaminathan K, Chatterjee S, and Dey A. Apoptosis in HepG2 cells exposed to high glucose. Toxicol In Vitro 24: 387-396, 2010.
36. Chantret I, Rodolosse A, Barbat A, Dussaulx E, Brot-Laroche E, Zweibaum A, and Rousset M. Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: evidence for glucose-dependent negative regulation. J Cell Sci 107 (Pt 1): 213-225, 1994.
37. Chen Y, Cairns R, Papandreou I, Koong A, and Denko NC. Oxygen consumption can regulate the growth of tumors, a new perspective on the Warburg effect. PLoS One 4: e7033, 2009.
38. Chen Z, Shi T, Zhang L, Zhu P, Deng M, Huang C, Hu T, Jiang L, and Li J. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade. Cancer Lett 370: 153-164, 2016.
39. Choi EJ, Bae SM, and Ahn WS. Antiproliferative effects of quercetin through cell cycle arrest and apoptosis in human breast cancer MDA-MB-453 cells. Arch Pharm Res 31: 1281-1285, 2008.
40. Chou CC, Yang JS, Lu HF, Ip SW, Lo C, Wu CC, Lin JP, Tang NY, Chung JG, Chou MJ, Teng YH, and Chen DR. Quercetin-mediated cell cycle arrest and apoptosis involving activation of a caspase cascade through the mi-tochondrial pathway in human breast cancer MCF-7 cells. Arch Pharm Res 33: 1181-1191, 2010.
41. Cianci M, Folli C, Zonta F, Florio P, Berni R, and Zanotti G. Structural evidence for asymmetric ligand binding to transthyretin. Acta Crystallogr D Biol Crystallogr 71: 1582-1592, 2015.
42. Cifuentes-Gomez T, Rodriguez-Mateos A, Gonzalez-Salvador I, Alanon ME, and Spencer JP. Factors affecting the absorption, metabolism, and excretion of cocoa fla-vanols in humans. J Agric Food Chem 63: 7615-7623, 2015.
43. Clifford MN, van der Hooft JJ, and Crozier A. Human studies on the absorption, distribution, metabolism, and excretion of tea polyphenols. Am J Clin Nutr 98: 1619S-1630S, 2013.
44. Cordero-Herrera I, Martin MA, Goya L, and Ramos S. Cocoa flavonoids attenuate high glucose-induced insulin signalling blockade and modulate glucose uptake and production in human HepG2 cells. Food Chem Toxicol 64: 10-19, 2014.
45. Coskun O, Kanter M, Korkmaz A, and Oter S. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pan-creas. Pharmacol Res 51: 117-123, 2005.
46. Costantini S, Di Bernardo G, Cammarota M, Castello G, and Colonna G. Gene expression signature of human HepG2 cell line. Gene 518: 335-345, 2013.
47. Couse JF and Korach KS. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20: 358-417, 1999.
48. Cunningham P, Afzal-Ahmed I, and Naftalin RJ. Docking studies show that D-glucose and quercetin slide through the transporter GLUT1. J Biol Chem 281: 5797-5803, 2006.
49. Daniels VW, Smans K, Royaux I, Chypre M, Swinnen JV, and Zaidi N. Cancer cells differentially activate and thrive on de novo lipid synthesis pathways in a low-lipid environment. PLoS One 9: e106913, 2014.
50. Datsyuk OI. [Impact of quercetin on systemic and splanchnic blood circulation in a complex of preoperative preparation in patients, suffering an acute pancreatitis]. Klin Khir 13-15, 2016.
51. Day AJ, Bao Y, Morgan MRA, and Williamson G. Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic Biol Med 29: 1234-1243, 2000.
52. Day AJ, Canada FJ, Diaz JC, Kroon PA, McLauchlan WR, Faulds CB, Plumb GW, Morgan MRA, and Wil-liamson G. Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett 468: 166-170, 2000.
53. Day AJ, Mellon F, Barron D, Sarrazin G, Morgan MR, and Williamson G. Human metabolism of dietary flavo-noids: identification of plasma metabolites of quercetin. Free Radic Res 35: 941-952, 2001.
54. Deb G, Thakur VS, Limaye AM, and Gupta S. Epigenetic induction of tissue inhibitor of matrix metalloproteinase-3 by green tea polyphenols in breast cancer cells. Mol Carcinog 54: 485-499, 2015.
55. Del Rio D, Rodriguez-Mateos A, Spencer JP, Tognolini M, Borges G, and Crozier A. Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal 18: 1818-1892, 2013.
56. Deng XH, Song HY, Zhou YF, Yuan GY, and Zheng FJ. Effects of quercetin on the proliferation of breast cancer cells and expression of survivin in vitro. Exp Ther Med 6: 1155-1158, 2013.
57. Diers AR, Broniowska KA, Chang CF, and Hogg N. Pyruvate fuels mitochondrial respiration and proliferation of breast cancer cells: effect of monocarboxylate transporter inhibition. Biochem J 444: 561-571, 2012.
58. Dihal AA, Tilburgs C, van Erk MJ, Rietjens IM, Wou-tersen RA, and Stierum RH. Pathway and single gene analyses of inhibited Caco-2 differentiation by ascorbate-stabilized quercetin suggest enhancement of cellular processes associated with development of colon cancer. Mol Nutr Food Res 51: 1031-1045, 2007.
59. Dihal AA, van der Woude H, Hendriksen PJ, Charif H, Dekker LJ, Ijsselstijn L, de Boer VC, Alink GM, Burgers PC, Rietjens IM, Woutersen RA, and Stierum RH. Tran-scriptome and proteome profiling of colon mucosa from quercetin fed F344 rats point to tumor preventive mech-anisms, increased mitochondrial fatty acid degradation and decreased glycolysis. Proteomics 8: 45-61, 2008.
60. Dinkova-Kostova AT and Abramov AY. The emerging role of Nrf2 in mitochondrial function. Free Radic Biol Med 88: 179-188, 2015.
61. Doherty GA, Byrne SM, Austin SC, Scully GM, Sadlier DM, Neilan TG, Kay EW, Murray FE, and Fitzgerald DJ. Regulation of the apoptosis-inducing kinase DRAK2 by cyclooxygenase-2 in colorectal cancer. Br J Cancer 101: 483-491, 2009.
62. Du G, Lin H, Wang M, Zhang S, Wu X, Lu L, Ji L, and Yu L. Quercetin greatly improved therapeutic index of doxorubicin against 4T1 breast cancer by its opposing effects on HIF-1alpha in tumor and normal cells. Cancer Chemother Pharmacol 65: 277-287, 2010.
63. Du G, Lin H, Yang Y, Zhang S, Wu X, Wang M, Ji L, Lu L, Yu L, and Han G. Dietary quercetin combining in-tratumoral doxorubicin injection synergistically induces rejection of established breast cancer in mice. Int Im-munopharmacol 10: 819-826, 2010.
64. Dupuy F, Tabaries S, Andrzejewski S, Dong Z, Blagih J, Annis MG, Omeroglu A, Gao D, Leung S, Amir E, Clemons M, Aguilar-Mahecha A, Basik M, Vincent EE, St-Pierre J, Jones RG, and Siegel PM. PDK1-dependent metabolic reprogramming dictates metastatic potential in breast cancer. Cell Metab 22: 577-589, 2015.
65. Eisenberg ML, Maker AV, Slezak LA, Nathan JD, Sri-tharan KC, Jena BP, Geibel JP, and Andersen DK. Insulin receptor (IR) and glucose transporter 2 (GLUT2) proteins form a complex on the rat hepatocyte membrane. Cell Physiol Biochem 15: 51-58, 2005.
66. Ekstrom AM, Serafini M, Nyren O, Wolk A, Bosetti C, and Bellocco R. Dietary quercetin intake and risk of gastric cancer: results from a population-based study in Sweden. Ann Oncol 22: 438-443, 2011.
67. Eleazu CO, Eleazu KC, Chukwuma S, and Essien UN. Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans. J Diabetes Metab Disord 12: 60, 2013.
68. Englund G, Rorsman F, Ronnblom A, Karlbom U, La-zorova L, Grasjo J, Kindmark A, and Artursson P. Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC trans-porters and comparison with Caco-2 cells. Eur J Pharm Sci 29: 269-277, 2006.
69. Escande C, Nin V, Price NL, Capellini V, Gomes AP, Barbosa MT, O'Neil L, White TA, Sinclair DA, and Chini EN. Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome. Diabetes 62: 1084-1093, 2013.
70. Favreau LV and Pickett CB. Transcriptional regulation of the rat NAD(p)H:quinone reductase gene. J Biol Chem 266: 4556-4561, 1991.
71. Ferry DR, Smith A, Malkhandi J, Fyfe DW, Detakats PG, Anderson D, Baker J, and Kerr DJ. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res 2: 659-668, 1996.
72. Fiorani M, Guidarelli A, Blasa M, Azzolini C, Candiracci M, Piatti E, and Cantoni O. Mitochondria accumulate large amounts of quercetin: prevention of mitochondrial damage and release upon oxidation of the extra-mitochondrial fraction of the flavonoid. J Nutr Biochem 21: 397-404, 2010.
73. Fujiki H, Suganuma M, Okabe S, Sueoka E, Suga K, Imai K, Nakachi K, and Kimura S. Mechanistic findings of green tea as cancer preventive for humans. Proc Soc Exp Biol Med 220: 225-228, 1999.
74. Galbusera C, Orth P, Fedida D, and Spector T. Superoxide radical production by allopurinol and xanthine oxidase. Biochem Pharmacol 71: 1747-1752, 2006.
75. Galindo P, Rodriguez-Gomez I, Gonzalez-Manzano S, Duenas M, Jimenez R, Menendez C, Vargas F, Tamargo J, Santos-Buelga C, Perez-Vizcaino F, and Duarte J. Glu-curonidated quercetin lowers blood pressure in spontaneously hypertensive rats via deconjugation. PLoS One 7: e32673, 2012.
76. Gao X and Schottker B. Reduction-oxidation pathways involved in cancer development: a systematic review of literature reviews. Oncotarget 8: 51888-51906, 2017.
77. Gatzka M, Newton RH, and Walsh CM. Altered thymic selection and increased autoimmunity caused by ectopic expression of DRAK2 during T cell development. J Immunol 183: 285-297, 2009.
78. Gautier-Stein A, Soty M, Chilloux J, Zitoun C, Rajas F, and Mithieux G. Glucotoxicity induces glucose-6-phosphatase catalytic unit expression by acting on the interaction of HIF-1alpha with CREB-binding protein. Diabetes 61: 2451-2460, 2012.
79. Gee JM, DuPont MS, Rhodes MJ, and Johnson IT. Quercetin glucosides interact with the intestinal glucose transport pathway. Free Radic Biol Med 25: 19-25, 1998.
80. Gentric G, Mieulet V, and Mechta-Grigoriou F. Heterogeneity in cancer metabolism: new concepts in an old field. Antioxid Redox Signal 26: 462-485, 2017.
81. Geraets L, Moonen HJ, Brauers K, Wouters EF, Bast A, and Hageman GJ. Dietary flavones and flavonoles are inhibitors of poly(ADP-ribose)polymerase-1 in pulmonary epithelial cells. J Nutr 137: 2190-2195, 2007.
82. Gerk PM and Vore M. Regulation of expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition. J Pharmacol Exp Ther 302: 407-415, 2002.
83. Gledhill JR, Montgomery MG, Leslie AG, and Walker JE. Mechanism of inhibition of bovine F1-ATPase by res-veratrol and related polyphenols. Proc Natl Acad Sci USA 104: 13632-13637, 2007.
84. Gnoni GV, Paglialonga G, and Siculella L. Quercetin inhibits fatty acid and triacylglycerol synthesis in rat-liver cells. Eur J Clin Invest 39: 761-768, 2009.
85. Gong L, Zhu L, Wang S, and Zhang Z. Transthyretin regulates the migration and invasion of JEG-3 cells. Oncol Lett 13: 1242-1246, 2017.
86. Govind PT, Suiko M, Sakakibara Y, and Ming CL. Sul-fation of flavonoids and other phenolic dietary compounds by the human cytosolic sulfotransferases. Biochem Bio-phys Res Commun 285: 1175-1179, 2001.
87. Granado-Serrano AB, Martin MA, Bravo L, Goya L, and Ramos S. Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2). J Nutr 136: 2715-2721, 2006.
88. Granado-Serrano AB, Martin MA, Bravo L, Goya L, and Ramos S. Quercetin attenuates TNF-induced inflammation in hepatic cells by inhibiting the NF-kappaB pathway. Nutr Cancer 64: 588-598, 2012.
89. Grassian AR, Metallo CM, Coloff JL, Stephanopoulos G, and Brugge JS. Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation. Genes Dev 25: 1716-1733, 2011.
90. Gugler R, Leschik M, and Dengler HJ. Disposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol 9: 229-234, 1975.
91. Gunther S, Ruhe C, Derikito MG, Bose G, Sauer H, and Wartenberg M. Polyphenols prevent cell shedding from mouse mammary cancer spheroids and inhibit cancer cell invasion in confrontation cultures derived from embryonic stem cells. Cancer Lett 250: 25-35, 2007.
92. Guo L, Dial S, Shi L, Branham W, Liu J, Fang JL, Green B, Deng H, Kaput J, and Ning B. Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes. Drug Metab Dispos 39: 528-538, 2011.
93. Gutmann H, Fricker G, Torok M, Michael S, Beglinger C, and Drewe J. Evidence for different ABC-transporters in Caco-2 cells modulating drug uptake. Pharm Res 16: 402-407, 1999.
94. Hah J, Jo I, Chakrabarti R, and Jung CY. Demonstration of an insulin-insensitive storage pool of glucose transporters in rat hepatocytes and HepG2 cells. J Cell Physiol 152: 56-63, 1992.
95. Hanahan D and Weinberg RA. Hallmarks of cancer: the next generation. Cell 144: 646-674, 2011.
96. Hardie DG. AMPK: a target for drugs and natural products with effects on both diabetes and cancer. Diabetes 62: 2164-2172, 2013.
97. Hawes JW, Jaskiewicz J, Shimomura Y, Huang B, Bunting J, Harper ET, and Harris RA. Primary structure and tissue-specific expression of human beta-hydroxyisobutyryl-coenzyme A hydrolase. J Biol Chem 271: 26430-26434, 1996.
98. Hayes JD and Ashford ML. Nrf2 orchestrates fuel partitioning for cell proliferation. Cell Metab 16: 139-141, 2012.
99. Hirayama B, Lostao MP, Panayotova-Heiermann M, Loo DDF, Turk E, and Wright EM. Kinetic and specificity differences between rat, human, and rabbit Na+-glucose cotransporters (SGLT-1). Am J Physiol 270: G919-G926, 1999.
100. Holder S, Zemskova M, Zhang C, Tabrizizad M, Bremer R, Neidigh JW, and Lilly MB. Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase. Mol Cancer Ther 6: 163-172, 2007.
101. Hong YJ and Mitchell AE. Identification of glutathione-related quercetin metabolites in humans. Chem Res Tox-icol 19: 1525-1532, 2006.
102. Huang D, Ou B, and Prior RL. The chemistry behind antioxidant capacity assays. J Agric Food Chem 53: 1841-1856, 2005.
103. Hybertson BM, Gao B, Bose SK, and McCord JM. Oxi-dative stress in health and disease: the therapeutic potential of Nrf2 activation. Mol Aspects Med 32: 234-246, 2011.
104. Ikei S, Ogawa M, and Yamaguchi Y. Blood concentrations of polymorphonuclear leucocyte elastase and interleukin-6 are indicators for the occurrence of multiple organ failures at the early stage of acute pancreatitis. J Gastroenterol Hepatol 13: 1274-1283, 1998.
105. Ishigure K, Shimomura Y, Murakami T, Kaneko T, Ta-keda S, Inoue S, Nomoto S, Koshikawa K, Nonami T, and Nakao A. Human liver disease decreases methacrylyl-CoA hydratase and beta-hydroxyisobutyryl-CoA hydro-lase activities in valine catabolism. Clin Chim Acta 312: 115-121, 2001.
106. Ishisaka A, Kawabata K, Miki S, Shiba Y, Minekawa S, Nishikawa T, Mukai R, Terao J, and Kawai Y. Mi-tochondrial dysfunction leads to deconjugation of quer-cetin glucuronides in inflammatory macrophages. PLoS One 8: e80843, 2013.
107. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M, and Nabeshima Y. An Nrf2/small maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant elements. Biochem Biophys Res Commun 236: 313-322, 1997.
108. Javaid A and Bonkovsky HL. Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): a growing concern. J Hepatol 45: 334-335; author reply 335-336, 2006.
109. Jeon SM, Chandel NS, and Hay N. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 485: 661-665, 2012.
110. Kamaraj S, Vinodhkumar R, Anandakumar P, Jagan S, Ramakrishnan G, and Devaki T. The effects of quercetin on antioxidant status and tumor markers in the lung and serum of mice treated with benzo(a)pyrene. Biol Pharm Bull 30: 2268-2273, 2007.
111. Karim S, Adams DH, and Lalor PF. Hepatic expression and cellular distribution of the glucose transporter family. World J Gastroenterol 18: 6771-6781, 2012.
112. Kawai Y, Garduno L, Theodore M, Yang J, and Arinze IJ. Acetylation-deacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) regulates its transcriptional activity and nucleocytoplasmic localization. J Biol Chem 286: 7629-7640, 2011.
113. Kawai Y, Nishikawa T, Shiba Y, Saito S, Murota K, Shibata N, Kobayashi M, Kanayama M, Uchida K, and Terao J. Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the anti-atherosclerotic mechanism of dietary flavonoids. J Biol Chem 283: 9424-9434, 2008.
114. Kellett GL, Brot-Laroche E, Mace OJ, and Leturque A. Sugar absorption in the intestine: the role of GLUT2. Annu Rev Nutr 28: 35-54, 2008.
115. Kellogg EW, III and Fridovich I. Superoxide, hydrogen peroxide, and singlet oxygen in lipid peroxidation by a xanthine oxidase system. J Biol Chem 250: 8812-8817, 1975.
116. Kerimi A, Jailani F, and Williamson G. Modulation of cellular glucose metabolism in human HepG2 cells by combinations of structurally related flavonoids. Mol Nutr Food Res 59: 894-906, 2015.
117. Kerimi A and Williamson G. At the interface of antioxi-dant signalling and cellular function: key polyphenol effects. Mol Nutr Food Res 60: 1770-1788, 2016.
118. Kim GN and Jang HD. Protective mechanism of quercetin and rutin using glutathione metabolism on HO-induced oxidative stress in HepG2 cells. Ann N Y Acad Sci 1171: 530-537, 2009.
119. Kim JH, Kim MJ, Choi KC, and Son J. Quercetin sensitizes pancreatic cancer cells to TRAIL-induced apoptosis through JNK-mediated cFLIP turnover. Int J Biochem Cell Biol 78: 327-334, 2016.
120. Kim MJ, Ryu GR, Chung JS, Sim SS, Min DS, Rhie DJ, Yoon SH, Hahn SJ, Kim MS, and Jo YH. Protective ef-fects of epicatechin against the toxic effects of strepto-zotocin on rat pancreatic islets: in vivo and in vitro. Pancreas 26: 292-299, 2003.
121. Kim MJ, Ryu GR, Kang JH, Sim SS, Min DS, Rhie DJ, Yoon SH, Hahn SJ, Jeong IK, Hong KJ, Kim MS, and Jo YH. Inhibitory effects of epicatechin on interleukin-1beta-induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by down-regulation of NF-kappaB activation. Biochem Pharmacol 68: 1775-1785, 2004.
122. Kluth D, Banning A, Paur I, Blomhoff R, and Brigelius-Flohe R. Modulation of pregnane X receptor-and elec-trophile responsive element-mediated gene expression by dietary polyphenolic compounds. Free Radic Biol Med 42: 315-325, 2007.
123. Konig J, Nies AT, Cui YH, Leier I, and Keppler D. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta Biomemb 1461: 377-394, 1999.
124. Kroon PA, Clifford MN, Crozier A, Day AJ, Donovan JL, Manach C, and Williamson G. How should we assess the effects of exposure to dietary polyphenols in vitro? Am J Clin Nutr 80: 15-21, 2004.
125. Kurbitz C, Heise D, Redmer T, Goumas F, Arlt A, Lemke J, Rimbach G, Kalthoff H, and Trauzold A. Epicatechin gallate and catechin gallate are superior to epigalloca-techin gallate in growth suppression and anti-inflammatory activities in pancreatic tumor cells. Cancer Sci 102: 728-734, 2011.
126. Kushima Y, Iida K, Nagaoka Y, Kawaratani Y, Shirahama T, Sakaguchi M, Baba K, Hara Y, and Uesato S. Inhibitory effect of (-)-epigallocatechin and (-)-epigallocatechin gallate against heregulin beta1-induced migration/invasion of the MCF-7 breast carcinoma cell line. Biol Pharm Bull 32: 899-904, 2009.
127. Kwon O, Eck P, Chen S, Corpe CP, Lee JH, Kruhlak M, and Levine M. Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. FASEB J 21: 366-377, 2007.
128. Lee KW, Kang NJ, Heo YS, Rogozin EA, Pugliese A, Hwang MK, Bowden GT, Bode AM, Lee HJ, and Dong Z. Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major fla-vonol in red wine. Cancer Res 68: 946-955, 2008.
129. Lee YK and Park OJ. Regulation of mutual inhibitory activities between AMPK and Akt with quercetin in MCF-7 breast cancer cells. Oncol Rep 24: 1493-1497, 2010.
130. Lemmens KJ, Vrolijk MF, Bouwman FG, van der Vijgh WJ, Bast A, and Haenen GR. The minor structural dif-ference between the antioxidants quercetin and 4¢O-methylquercetin has a major impact on their selective thiol toxicity. Int J Mol Sci 15: 7475-7484, 2014.
131. Li C, Zhang WJ, Choi J, and Frei B. Quercetin affects glutathione levels and redox ratio in human aortic endo-thelial cells not through oxidation but formation and cellular export of quercetin-glutathione conjugates and upregulation of glutamate-cysteine ligase. Redox Biol 9: 220-228, 2016.
132. Li JM, Wang W, Fan CY, Wang MX, Zhang X, Hu QH, and Kong LD. Quercetin preserves beta-cell mass and function in fructose-induced hyperinsulinemia through modulating pancreatic Akt/FoxO1 activation. Evid Based Complement Alternat Med 2013: 303902, 2013.
133. Li L, Stanton JD, Tolson AH, Luo Y, and Wang H. Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive an-drostane receptor, and aryl hydrocarbon receptor-mediated pathways. Pharm Res 26: 872-882, 2009.
134. Li SZ, Qiao SF, Zhang JH, and Li K. Quercetin increase the chemosensitivity of breast cancer cells to doxorubicin via PTEN/Akt pathway. Anticancer Agents Med Chem 15: 1185-1189, 2015.
135. Li W, Chen C, Zhao X, Ye H, Zhao Y, Fu Z, Pan W, Zheng S, Wei L, Nong T, Li Z, and Chen R. HIF-2alpha regulates non-canonical glutamine metabolism via activation of PI3K/mTORC2 pathway in human pancreatic ductal adenocarcinoma. J Cell Mol Med 2017. DOI: 10.1111/jcmm.13202
136. Liang JH, Li YN, Qi JS, and Jia XX. Peroxynitrite-induced protein nitration is responsible for renal mito-chondrial damage in diabetic rat. J Endocrinol Invest 33: 140-146, 2010.
137. Lim JH, Luo C, Vazquez F, and Puigserver P. Targeting mitochondrial oxidative metabolism in melanoma causes metabolic compensation through glucose and glutamine utilization. Cancer Res 74: 3535-3545, 2014.
138. Lin CL and Lin JK. Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells. Mol Nutr Food Res 52: 930-939, 2008.
139. Lin S, Zhang G, Liao Y, Pan J, and Gong D. Dietary flavonoids as xanthine oxidase inhibitors: structure-affinity and structure-activity relationships. J Agric Food Chem 63: 7784-7794, 2015.
140. Lv Q, Meng XF, He FF, Chen S, Su H, Xiong J, Gao P, Tian XJ, Liu JS, Zhu ZH, Huang K, and Zhang C. High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies. PLoS One 8: e56864, 2013.
141. Magesh S, Chen Y, and Hu L. Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents. Med Res Rev 32: 687-726, 2012.
142. Manach C, Williamson G, Morand C, Scalbert A, and Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81: 230S-242S, 2005.
143. Mao J, Qiao X, Luo H, and Wu J. Transgenic drak2 overexpression in mice leads to increased T cell apoptosis and compromised memory T cell development. J Biol Chem 281: 12587-12595, 2006.
144. Marroquin LD, Hynes J, Dykens JA, Jamieson JD, and Will Y. Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants. Toxicol Sci 97: 539-547, 2007.
145. Martin HJ, Kornmann F, and Fuhrmann GF. The inhibitory effects of flavonoids and antiestrogens on the Glut1 glucose transporter in human erythrocytes. Chem Biol Interact 146: 225-235, 2003.
146. Martin MA, Fernandez-Millan E, Ramos S, Bravo L, and Goya L. Cocoa flavonoid epicatechin protects pancreatic beta cell viability and function against oxidative stress. Mol Nutr Food Res 58: 447-456, 2014.
147. Matsumoto H, Ikoma Y, Sugiura M, Yano M, and Hase-gawa Y. Identification and quantification of the conjugated metabolites derived from orally administered hesperidin in rat plasma. J Agric Food Chem 52: 6653-6659, 2004.
148. Maurya AK and Vinayak M. Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line. Mol Biol Rep 42: 1419-1429, 2015.
149. Mazzanti G, Menniti-Ippolito F, Moro PA, Cassetti F, Raschetti R, Santuccio C, and Mastrangelo S. Hepato-toxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol 65: 331-341, 2009.
150. Mazzarelli P, Pucci S, Bonanno E, Sesti F, Calvani M, and Spagnoli LG. Carnitine palmitoyltransferase I in human carcinomas: a novel role in histone deacetylation? Cancer Biol Ther 6: 1606-1613, 2007.
151. McGargill MA, Wen BG, Walsh CM, and Hedrick SM. A deficiency in Drak2 results in a T cell hypersensitivity and an unexpected resistance to autoimmunity. Immunity 21: 781-791, 2004.
152. McLarty J, Bigelow RL, Smith M, Elmajian D, Ankem M, and Cardelli JA. Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. Cancer Prev Res (Phila) 2: 673-682, 2009.
153. Meissen JK, Hirahatake KM, Adams SH, and Fiehn O. Temporal metabolomic responses of cultured HepG2 liver cells to high fructose and high glucose exposures. Meta-bolomics 11: 707-721, 2015.
154. Menendez C, Duenas M, Galindo P, Gonzalez-Manzano S, Jimenez R, Moreno L, Zarzuelo MJ, Rodriguez-Gomez I, Duarte J, Santos-Buelga C, and Perez-Vizcaino F. Vascular deconjugation of quercetin glucuronide: the fla-vonoid paradox revealed? Mol Nutr Food Res 55: 1780-1790, 2011.
155. Mennen LI, Sapinho D, Ito H, Bertrais S, Galan P, Hercberg S, and Scalbert A. Urinary flavonoids and phenolic acids as biomarkers of intake for polyphenol-rich foods. Br J Nutr 96: 191-198, 2006.
156. Meredith D and Christian HC. The SLC16 mono-caboxylate transporter family. Xenobiotica 38: 1072-1106, 2008.
157. Meyers MB, Scotto KW, and Sirotnak FM. P-glycoprotein content and mediation of vincristine efflux: correlation with the level of differentiation in luminal epithelium of mouse small intestine. Cancer Commun 3: 159-165, 1991.
158. Mitaine-Offer AC, Hornebeck W, Sauvain M, and Zeches-Hanrot M. Triterpenes and phytosterols as human leucocyte elastase inhibitors. Planta Med 68: 930-932, 2002.
159. Mitsuishi Y, Taguchi K, Kawatani Y, Shibata T, Nukiwa T, Aburatani H, Yamamoto M, and Motohashi H. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 22: 66-79, 2012.
160. Moarefi I, LaFevre-Bernt M, Sicheri F, Huse M, Lee CH, Kuriyan J, and Miller WT. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature 385: 650-653, 1997.
161. Moreira L, Araujo I, Costa T, Correia-Branco A, Faria A, Martel F, and Keating E. Quercetin and epigallocatechin gallate inhibit glucose uptake and metabolism by breast cancer cells by an estrogen receptor-independent mechanism. Exp Cell Res 319: 1784-1795, 2013.
162. Mostafavi-Pour Z, Ramezani F, Keshavarzi F, and Samadi N. The role of quercetin and vitamin C in Nrf2-dependent oxidative stress production in breast cancer cells. Oncol Lett 13: 1965-1973, 2017.
163. Mu C, Jia P, Yan Z, Liu X, Li X, and Liu H. Quercetin induces cell cycle G1 arrest through elevating Cdk inhibitors p21 and p27 in human hepatoma cell line (HepG2). Methods Find Exp Clin Pharmacol 29: 179-183, 2007.
164. Mullen W, Boitier A, Stewart AJ, and Crozier A. Flavo-noid metabolites in human plasma and urine after the consumption of red onions: analysis by liquid chroma-tography with photodiode array and full scan tandem mass spectrometric detection. J Chromatogr A 1058: 163-168, 2004.
165. Mullen W, Edwards CA, and Crozier A. Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl-and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions. Br J Nutr 96: 107-116, 2006.
166. Murakami S, Muramatsu M, and Otomo S. Inhibition of gastric H+, K(+)-ATPase by quercetin. J Enzyme Inhib 5: 293-298, 1992.
167. 2)-induced NF-kappaB DNA binding activity and DNA damage in HepG2 cells. Carci-nogenesis 19: 1583-1589, 1998.
168. Musonda CA, Helsby N, and Chipman JK. Effects of quercetin on drug metabolizing enzymes and oxidation of 2¢, 7-dichlorofluorescin in HepG2 cells. Hum Exp Toxicol 16: 700-708, 1997.
169. Mutch DM, Crespy V, Clough J, Henderson CJ, Lariani S, Mansourian R, Moulin J, Wolf CR, and Williamson G. Hepatic cytochrome P-450 reductase-null mice show reduced transcriptional response to quercetin and reveal physiological homeostasis between jejunum and liver. Am J Physiol Gastrointest Liver Physiol 291: G63-G72, 2006.
170. Mylona E, Magkou C, Giannopoulou I, Agrogiannis G, Markaki S, Keramopoulos A, and Nakopoulou L. Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: relation to tumor phenotype and clinical outcome. Breast Cancer Res 8: R57, 2006.
171. Nakajima K, Yamauchi K, Shigematsu S, Ikeo S, Ko-matsu M, Aizawa T, and Hashizume K. Selective attenuation of metabolic branch of insulin receptor down-signaling by high glucose in a hepatoma cell line, HepG2 cells. J Biol Chem 275: 20880-20886, 2000.
172. Natsume Y, Ito S, Satsu H, and Shimizu M. Protective effect of quercetin on ER stress caused by calcium dynamics dysregulation in intestinal epithelial cells. Toxicology 258: 164-175, 2009.
173. Natsume Y, Kadota K, Satsu H, and Shimizu M. Effect of quercetin on the gene expression profile of the mouse intestine. Biosci Biotechnol Biochem 73: 722-725, 2009.
174. Navarro VJ, Khan I, Bjornsson E, Seeff LB, Serrano J, and Hoofnagle JH. Liver injury from herbal and dietary supplements. Hepatology 65: 363-373, 2017.
175. Nelson LE, Valentine RJ, Cacicedo JM, Gauthier MS, Ido Y, and Ruderman NB. A novel inverse relationship between metformin-triggered AMPK-SIRT1 signaling and p53 protein abundance in high glucose-exposed HepG2 cells. Am J Physiol Cell Physiol 303: C4-C13, 2012.
176. Notas G, Nifli AP, Kampa M, Pelekanou V, Alexaki VI, Theodoropoulos P, Vercauteren J, and Castanas E. Quer-cetin accumulates in nuclear structures and triggers specific gene expression in epithelial cells. J Nutr Biochem 23: 656-666, 2012.
177. Nwaeburu CC, Bauer N, Zhao Z, Abukiwan A, Gladkich J, Benner A, and Herr I. Up-regulation of microRNA let-7c by quercetin inhibits pancreatic cancer progression by activation of Numbl. Oncotarget 7: 58367-58380, 2016.
178. Ohno S and Nakajin S. Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction. Drug Metab Dispos 37: 32-40, 2009.
179. Ono T, Tsuruta R, Fujita M, Aki HS, Kutsuna S, Kawa-mura Y, Wakatsuki J, Aoki T, Kobayashi C, Kasaoka S, Maruyama I, Yuasa M, and Maekawa T. Xanthine oxidase is one of the major sources of superoxide anion radicals in blood after reperfusion in rats with forebrain ischemia/reperfusion. Brain Res 1305: 158-167, 2009.
180. Osburn WO, Wakabayashi N, Misra V, Nilles T, Biswal S, Trush MA, and Kensler TW. Nrf2 regulates an adaptive response protecting against oxidative damage following diquat-mediated formation of superoxide anion. Arch Biochem Biophys 454: 7-15, 2006.
181. Pang J, Xi C, Dai Y, Gong H, and Zhang TM. Altered expression of base excision repair genes in response to high glucose-induced oxidative stress in HepG2 hepato-cytes. Med Sci Monit 18: BR281-BR285, 2012.
182. Papandreou I, Krishna C, Kaper F, Cai D, Giaccia AJ, and Denko NC. Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment. Cancer Res 65: 3171-3178, 2005.
183. Paranjpe A and Srivenugopal KS. Degradation of NF-kappaB, p53 and other regulatory redox-sensitive proteins by thiol-conjugating and-nitrosylating drugs in human tumor cells. Carcinogenesis 34: 990-1000, 2013.
184. Park H and Jeoung NH. Inflammation increases pyruvate dehydrogenase kinase 4 (PDK4) expression via the Jun N-Terminal Kinase (JNK) pathway in C2C12 cells. Biochem Biophys Res Commun 469: 1049-1054, 2016.
185. Pereira-Caro G, Borges G, Ky I, Ribas A, Calani L, Del Rio D, Clifford MN, Roberts SA, and Crozier A. In vitro colonic catabolism of orange juice (poly)phenols. Mol Nutr Food Res 59: 465-475, 2015.
186. Perez-Jimenez J, Hubert J, Hooper L, Cassidy A, Manach C, Williamson G, and Scalbert A. Urinary metabolites as biomarkers of polyphenol intake in humans: a systematic review. Am J Clin Nutr 92: 801-809, 2010.
187. Perez-Vizcaino F and Duarte J. Flavonols and cardiovascular disease. Mol Aspects Med 31: 478-494, 2010.
188. Perez A, Gonzalez-Manzano S, Jimenez R, Perez-Abud R, Haro JM, Osuna A, Santos-Buelga C, Duarte J, and Perez-and Vizcaino F. The flavonoid quercetin induces acute vasodilator effects in healthy volunteers: correlation with beta-glucuronidase activity. Pharmacol Res 89: 11-18, 2014.
189. Petri N, Tannergren C, Holst B, Mellon FA, Bao Y, Plumb GW, Bacon J, O'Leary KA, Kroon PA, Knutson L, Forsell P, Eriksson T, Lennernas H, and Williamson G. Absorption/metabolism of sulforaphane and quercetin, and reg-ulation of phase ii enzymes, in human jejunum in vivo. Drug Metab Dispos 31: 805-813, 2003.
190. Piconi L, Quagliaro L, and Ceriello A. Oxidative stress in diabetes. Clin Chem Lab Med 41: 1144-1149, 2003.
191. Pimpao RC, Dew T, Figueira ME, McDougall GJ, Stewart D, Ferreira RB, Santos CN, and Williamson G. Urinary metabolite profiling identifies novel colonic metabolites and conjugates of phenolics in healthy volunteers. Mol Nutr Food Res 58: 1414-1425, 2014.
192. Pimpao RC, Ventura MR, Ferreira RB, Williamson G, and Santos CN. Phenolic sulfates as new and highly abundant metabolites in human plasma after ingestion of a mixed berry fruit puree. Br J Nutr 113: 454-463, 2015.
193. Pollard SE, Kuhnle GG, Vauzour D, Vafeiadou K, Tzounis X, Whiteman M, Rice-Evans C, and Spencer JP. The reaction of flavonoid metabolites with peroxynitrite. Biochem Biophys Res Commun 350: 960-968, 2006.
194. Postic C, Burcelin R, Rencurel F, Pegorier JP, Loizeau M, Girard J, and Leturque A. Evidence for a transient inhibitory effect of insulin on GLUT2 expression in the liver: studies in vivo and in vitro. Biochem J 293 (Pt 1): 119-124, 1993.
195. Price KR and Rhodes MJC. Analysis of the major flavonol glycosides present in four varieties of onion (Allium cepa) and changes in composition resulting from autolysis. J Sci Food Agric 74: 331-339, 1996.
196. Pucci S, Zonetti MJ, Fisco T, Polidoro C, Bocchinfuso G, Palleschi A, Novelli G, Spagnoli LG, and Mazzarelli P. Carnitine palmitoyl transferase-1A (CPT1A): a new tumor specific target in human breast cancer. Oncotarget 7: 19982-19996, 2016.
197. Quagliaro L, Piconi L, Assaloni R, Da RR, Szabo C, and Ceriello A. Primary role of superoxide anion generation in the cascade of events leading to endothelial dysfunction and damage in high glucose treated HUVEC. Nutr Metab Cardiovasc Dis 17: 257-267, 2007.
198. Ramos-Gomex M, Kwak M-K, Dolan PM, Itoh K, Ya-mamoto M, Talalay P, and Kensler TW. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. PNAS 98: 3410-3415, 2001.
199. Ranganathan S, Halagowder D, and Sivasithambaram ND. Quercetin suppresses twist to induce apoptosis in MCF-7 breast cancer cells. PLoS One 10: e0141370, 2015.
200. Rayamajhi N, Kim SK, Go H, Joe Y, Callaway Z, Kang JG, Ryter SW, and Chung HT. Quercetin induces mito-chondrial biogenesis through activation of HO-1 in HepG2 cells. Oxid Med Cell Longev 2013: 154279, 2013.
201. Reddy NM, Kleeberger SR, Yamamoto M, Kensler TW, Scollick C, Biswal S, and Reddy SP. Genetic dissection of the Nrf2-dependent redox signaling-regulated transcrip-tional programs of cell proliferation and cytoprotection. Physiol Genomics 32: 74-81, 2007.
202. Ren XY, Li YN, Qi JS, and Niu T. Peroxynitrite-induced protein nitration contributes to liver mitochondrial damage in diabetic rats. J Diabetes Complications 22: 357-364, 2008.
203. Rohr-Udilova N, Klinglmuller F, Seif M, Hayden H, Bilban M, Pinter M, Stolze K, Sieghart W, Peck-Radosavljevic M, and Trauner M. Oxidative stress mediates an increased formation of vascular endothelial growth factor in human hepatocarcinoma cells exposed to erloti-nib. Oncotarget 2017.
204. Rossi M, Maiuri L, Fusco MI, Salvati VM, Fuccio A, Auricchio S, Mantei N, Zecca L, Gloor SM, and Semenza G. Lastase persistence versus decline in human adults: multifactorial events are involved in down-regulation after weaning. Gastroenterology 112: 1506-1514, 1997.
205. Ruiz PA, Braune A, Holzlwimmer G, Quintanilla-Fend L, and Haller D. Quercetin inhibits TNF-induced NF-kappaB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells. J Nutr 137: 1208-1215, 2007.
206. Ruotolo R, Calani L, Brighenti F, Crozier A, Ottonello S, and Del Rio D. Glucuronidation does not suppress the estrogenic activity of quercetin in yeast and human breast cancer cell model systems. Arch Biochem Biophys 559: 62-67, 2014.
207. Sartor L, Pezzato E, and Garbisa S. (-)Epigallocatechin-3-gallate inhibits leukocyte elastase: potential of the phyto-factor in hindering inflammation, emphysema, and inva-sion. J Leukoc Biol 71: 73-79, 2002.
208. Secomb TW, Hsu R, Braun RD, Ross JR, Gross JF, and Dewhirst MW. Theoretical simulation of oxygen transport to tumors by three-dimensional networks of microvessels. Adv Exp Med Biol 454: 629-634, 1998.
209. Seithel A, Karlsson J, Hilgendorf C, Bjorquist A, and Ungell AL. Variability in mRNA expression of ABC-and SLC-transporters in human intestinal cells: comparison between human segments and Caco-2 cells. Eur J Pharm Sci 28: 291-299, 2006.
210. Semenkovich CF, Coleman T, and Goforth R. Physiologic concentrations of glucose regulate fatty acid synthase activity in HepG2 cells by mediating fatty acid synthase mRNA stability. J Biol Chem 268: 6961-6970, 1993.
211. Senger DR, Li D, Jaminet SC, and Cao S. Activation of the Nrf2 cell defense pathway by ancient foods: disease prevention by important molecules and microbes lost from the Modern Western Diet. PLoS One 11: e0148042, 2016.
212. Shi Y and Williamson G. Quercetin lowers plasma uric acid in pre-hyperuricaemic males: a randomised, double-blinded, placebo-controlled, cross-over trial. Br J Nutr 115: 800-806, 2016.
213. Shimomura Y, Honda T, Goto H, Nonami T, Kurokawa T, Nagasaki M, and Murakami T. Effects of liver failure on the enzymes in the branched-chain amino acid catabolic pathway. Biochem Biophys Res Commun 313: 381-385, 2004.
214. Shimomura Y, Murakami T, Nakai N, Huang B, Hawes JW, and Harris RA. 3-hydroxyisobutyryl-CoA hydrolase. Methods Enzymol 324: 229-240, 2000.
215. Sicheri F, Moarefi I, and Kuriyan J. Crystal structure of the Src family tyrosine kinase Hck. Nature 385: 602-609, 1997.
216. Siddique HR, Liao DJ, Mishra SK, Schuster T, Wang L, Matter B, Campbell PM, Villalta P, Nanda S, Deng Y, and Saleem M. Epicatechin-rich cocoa polyphenol inhibits Kras-activated pancreatic ductal carcinoma cell growth in vitro and in a mouse model. Int J Cancer 131: 1720-1731, 2012.
217. Sies H. Total antioxidant capacity: appraisal of a concept. J Nutr 137: 1493-1495, 2007.
218. Singh A, Bodas M, Wakabayashi N, Bunz F, and Biswal S. Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance. Antioxid Redox Signal 13: 1627-1637, 2010.
219. Singh A, Boldin-Adamsky S, Thimmulappa RK, Rath SK, Ashush H, Coulter J, Blackford A, Goodman SN, Bunz F, Watson WH, Gabrielson E, Feinstein E, and Biswal S. RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy. Cancer Res 68: 7975-7984, 2008.
220. Singh A, Wu H, Zhang P, Happel C, Ma J, and Biswal S. Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresis-tance phenotype. Mol Cancer Ther 9: 2365-2376, 2010.
221. Singh B, Mense SM, Bhat NK, Putty S, Guthiel WA, Remotti F, and Bhat HK. Dietary quercetin exacerbates the development of estrogen-induced breast tumors in female ACI rats. Toxicol Appl Pharmacol 247: 83-90, 2010.
222. Smirnova NA, Kaidery NA, Hushpulian DM, Rakhman, II, Poloznikov AA, Tishkov VI, Karuppagounder SS, Gaisina IN, Pekcec A, Leyen KV, Kazakov SV, Yang L, Thomas B, Ratan RR, and Gazaryan IG. Bioactive fla-vonoids and catechols as Hif1 and Nrf2 protein stabilizers-implications for Parkinson's disease. Aging Dis 7: 745-762, 2016.
223. Srivastava N, Kollipara RK, Singh DK, Sudderth J, Hu Z, Nguyen H, Wang S, Humphries CG, Carstens R, Huffman KE, DeBerardinis RJ, and Kittler R. Inhibition of cancer cell proliferation by PPARgamma is mediated by a metabolic switch that increases reactive oxygen species lev-els. Cell Metab 20: 650-661, 2014.
224. Steiner J, Davis J, McClellan J, Enos R, Carson J, Fayad R, Nagarkatti M, Nagarkatti P, Altomare D, Creek K, and Murphy E. Dose-dependent benefits of quercetin on tu-morigenesis in the C3(1)/SV40Tag transgenic mouse model of breast cancer. Cancer Biol Ther 15: 1456-1467, 2014.
225. Stevens JF and Maier CS. The chemistry of gut microbial metabolism of polyphenols. Phytochem Rev 1-20, 2016.
226. Sugino K, Nakamura Y, Muramatsu Y, Hata Y, Shibuya K, and Homma S. Analysis of blood neutrophil elastase, glutathione levels and pathological findings in postoperative acute exacerbation of idiopathic pulmonary fibrosis associated with lung cancer: two case reports. Mol Clin Oncol 5: 402-406, 2016.
227. Sun D, Lennernas H, Welage LS, Barnett JL, Landowski CP, Foster D, Fleisher D, Lee KD, and Amidon GL. Comparison of human duodenum and Caco-2 gene expression profiles for 12, 000 gene sequences tags and correlation with permeability of 26 drugs. Pharm Res 19: 1400-1416, 2002.
228. Suzuki T and Hara H. Quercetin enhances intestinal barrier function through the assembly of zonula [corrected] occludens-2, occludin, and claudin-1 and the expression of claudin-4 in Caco-2 cells. J Nutr 139: 965-974, 2009.
229. Syu JP, Chi JT, and Kung HN. Nrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxia. Oncotarget 7: 14659-14672, 2016.
230. Tachibana H, Koga K, Fujimura Y, and Yamada K. A receptor for green tea polyphenol EGCG. Nat Struct Mol Biol 11: 380-381, 2004.
231. Takanaga H, Chaudhuri B, and Frommer WB. GLUT1 and GLUT9 as major contributors to glucose influx in HepG2 cells identified by a high sensitivity intramolecular FRET glucose sensor. Biochim Biophys Acta 1778: 1091-1099, 2008.
232. Tan J, Wang B, and Zhu L. Regulation of survivin and Bcl-2 in HepG2 cell apoptosis induced by quercetin. Chem Biodivers 6: 1101-1110, 2009.
233. Tan J, Yang HS, and Patel MS. Regulation of mammalian pyruvate dehydrogenase alpha subunit gene expression by glucose in HepG2 cells. Biochem J 336 (Pt 1): 49-56, 1998.
234. Tanigawa S, Fujii M, and Hou DX. Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin. Free Radic Biol Med 42: 1690-1703, 2007.
235. Taniguchi K, Nonami T, Nakao A, Harada A, Kurokawa T, Sugiyama S, Fujitsuka N, Shimomura Y, Hutson SM, Harris RA, and Takagi H. The valine catabolic pathway in human liver: effect of cirrhosis on enzyme activities. Hepatology 24: 1395-1398, 1996.
236. Terao J, Murota K, and Kawai Y. Conjugated quercetin glucuronides as bioactive metabolites and precursors of aglycone in vivo. Food Funct 2: 11-17, 2011.
237. Terao J, Yamaguchi S, Shirai M, Miyoshi M, Moon JH, Oshima S, Inakuma T, Tsushida T, and Kato Y. Protection by quercetin and quercetin 3-O-beta-glueuronide of peroxynitrite-induced antioxidant consumption in human plasma low-density lipoprotein. Free Radic Res 35: 925-931, 2001.
238. Theodoratou E, Kyle J, Cetnarskyj R, Farrington SM, Tenesa A, Barnetson R, Porteous M, Dunlop M, and Campbell H. Dietary flavonoids and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 16: 684-693, 2007.
239. Thomasset SC, Berry DP, Garcea G, Marczylo T, Steward WP, and Gescher AJ. Dietary polyphenolic phytochemi-cals-promising cancer chemopreventive agents in humans? A review of their clinical properties. Int J Cancer 120: 451-458, 2007.
240. van DD, Jansen H, and Verhoeven AJ. Glucose increases hepatic lipase expression in HepG2 liver cells through upregulation of upstream stimulatory factors 1 and 2. Diabetologia 51: 2078-2087, 2008.
241. Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol 14: 198-206, 2004.
242. Vazquez F, Lim JH, Chim H, Bhalla K, Girnun G, Pierce K, Clish CB, Granter SR, Widlund HR, Spiegelman BM, and Puigserver P. PGC1alpha expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. Cancer Cell 23: 287-301, 2013.
243. Venugopal R and Jaiswal AK. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antiox-idant response element-mediated expression of NAD(P)H: quinone oxidoreductase(1) gene. Proc Natl Acad Sci USA 93: 14960-14965, 1996.
244. Vidyashankar S, Sandeep VR, and Patki PS. Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells. Toxicol In Vitro 27: 945-953, 2013.
245. von Kleist L, Michaelis S, Bartho K, Graebner O, Schlief M, Dreger M, Schrey AK, Sefkow M, Kroll F, Koester H, and Luo Y. Identification of potential off-target toxicity liabilities of catechol-O-methyltransferase inhibitors by differential competition capture compound mass spec-trometry. J Med Chem 59: 4664-4675, 2016.
246. Vrba J, Kren V, Vacek J, Papouskova B, and Ulrichova J. Quercetin, quercetin glycosides and taxifolin differ in their ability to induce AhR activation and CYP1A1 expression in HepG2 cells. Phytother Res 26: 1746-1752, 2012.
247. Waizenegger J, Lenze D, Luckert C, Seidel A, Lampen A, and Hessel S. Dose-dependent induction of signaling pathways by the flavonoid quercetin in human primary hepatocytes: a transcriptomic study. Mol Nutr Food Res 2015.
248. Wallace DC. Mitochondria and cancer. Nat Rev Cancer 12: 685-698, 2012.
249. Wang H, Tao L, Qi K, Zhang H, Feng D, Wei W, Kong H, Chen T, and Lin Q. Quercetin reverses tamoxifen resis-tance in breast cancer cells. J BUON 20: 707-713, 2015.
250. Wang J, Ye C, Chen C, Xiong H, Xie B, Zhou J, Chen Y, Zheng S, and Wang L. Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis. Oncotarget 8: 16875-16886, 2017.
251. Wang MD, Wu H, Fu GB, Zhang HL, Zhou X, Tang L, Dong LW, Qin CJ, Huang S, Zhao LH, Zeng M, Wu MC, Yan HX, and Wang HY. Acetyl-coenzyme A carboxylase alpha promotion of glucose-mediated fatty acid synthesis enhances survival of hepatocellular carcinoma in mice and patients. Hepatology 63: 1272-1286, 2016.
252. Wang P, Heber D, and Henning SM. Quercetin increased bioavailability and decreased methylation of green tea polyphenols in vitro and in vivo. Food Funct 3: 635-642, 2012.
253. Wang RE, Hunt CR, Chen J, and Taylor JS. Biotinylated quercetin as an intrinsic photoaffinity proteomics probe for the identification of quercetin target proteins. Bioorg Med Chem 19: 4710-4720, 2011.
254. Wang X, Wang Z, Liu JZ, Hu JX, Chen HL, Li WL, and Hai CX. Double antioxidant activities of rosiglitazone against high glucose-induced oxidative stress in hepato-cyte. Toxicol In Vitro 25: 839-847, 2011.
255. Wang XJ, Sun Z, Villeneuve NF, Zhang S, Zhao F, Li Y, Chen W, Yi X, Zheng W, Wondrak GT, Wong PK, and Zhang DD. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcino-genesis 29: 1235-1243, 2008.
256. Weijl NI, Elsendoorn TJ, Lentjes EG, Hopman GD, Wipkink-Bakker A, Zwinderman AH, Cleton FJ, and Osanto S. Supplementation with antioxidant micro-nutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study. Eur J Cancer 40: 1713-1723, 2004.
257. Wilkening S, Stahl F, and Bader A. Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab Dispos 31: 1035-1042, 2003.
258. Williamson G. Possible effects of dietary polyphenols on sugar absorption and digestion. Mol Nutr Food Res 57: 48-57, 2013.
259. Williamson G, Barron D, Shimoi K, and Terao J. In vitro biological properties of flavonoid conjugates found in vivo. Free Radic Res 39: 457-469, 2005.
260. Williamson G and Clifford MN. Role of the small intestine, colon and microbiota in determining the metabolic fate of polyphenols. Biochem Pharmacol 139: 24-39, 2017.
261. Winterbourn CC and Metodiewa D. Reactivity of biologically important thiol compounds with superoxide and hydrogen peroxide. Free Radic Biol Med 27: 322-328, 1999.
262. Wong CC, Akiyama Y, Abe T, Lippiat JD, Orfila C, and Williamson G. Carrier-mediated transport of quercetin conjugates: involvement of organic anion transporters and organic anion transporting polypeptides. Biochem Pharmacol 84: 564-570, 2012.
263. Wong CC, Botting NP, Orfila C, Al-Maharik N, and Williamson G. Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1/SLC22A6). Biochem Pharmacol 81: 942-949, 2011.
264. Wu X, Sun L, Wang X, Su P, Li Z, Zhang C, Wang Y, Gao P, and Ma R. Breast cancer invasion and metastasis by mPRalpha through the PI3K/Akt signaling pathway. Pathol Oncol Res 22: 471-476, 2016.
265. Xiang M, Namani A, Wu S, and Wang X. Nrf2: bane or blessing in cancer? J Cancer Res Clin Oncol 140: 1251-1259, 2014.
266. Xue M, Qian Q, Adaikalakoteswari A, Rabbani N, Babaei-Jadidi R, and Thornalley PJ. Activation of NF-E2-related factor-2 reverses biochemical dysfunction of en-dothelial cells induced by hyperglycemia linked to vascular disease. Diabetes 57: 2809-2817, 2008.
267. Xue M, Weickert MO, Qureshi S, Kandala NB, Anwar A, Waldron M, Shafie A, Messenger D, Fowler M, Jenkins G, Rabbani N, and Thornalley PJ. Improved glycemic control and vascular function in overweight and obese subjects by glyoxalase 1 inducer formulation. Diabetes 65: 2282-2294, 2016.
268. Yamazaki S, Miyoshi N, Kawabata K, Yasuda M, and Shimoi K. Quercetin-3-O-glucuronide inhibits noradrenaline-promoted invasion of MDA-MB-231 human breast cancer cells by blocking beta(2)-adrenergic signaling. Arch Biochem Biophys 557: 18-27, 2014.
269. Yang JH, Shin BY, Han JY, Kim MG, Wi JE, Kim YW, Cho IJ, Kim SC, Shin SM, and Ki SH. Isorhamnetin protects against oxidative stress by activating Nrf2 and inducing the expression of its target genes. Toxicol Appl Pharmacol 274: 293-301, 2014.
270. Yao P, Hao L, Nussler N, Lehmann A, Song F, Zhao J, Neuhaus P, Liu L, and Nussler A. The protective role of HO-1 and its generated products (CO, bilirubin, and Fe) in ethanol-induced human hepatocyte damage. Am J Physiol Gastrointest Liver Physiol 296: G1318-G1323, 2009.
271. Yao P, Nussler A, Liu L, Hao L, Song F, Schirmeier A, and Nussler N. Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK/Nrf2 pathways. J Hepatol 47: 253-261, 2007.
272. Yokoyama T, Kosaka Y, and Mizuguchi M. Structural insight into the interactions between death-associated protein kinase 1 and natural flavonoids. J Med Chem 58: 7400-7408, 2015.
273. Zang M, Zuccollo A, Hou X, Nagata D, Walsh K, Hers-covitz H, Brecher P, Ruderman NB, and Cohen RA. AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J Biol Chem 279: 47898-47905, 2004.
274. Zhang DD and Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol 23: 8137-8151, 2003.
275. Zhao JL, Zhao J, and Jiao HJ. Synergistic growth-suppressive effects of quercetin and cisplatin on HepG2 human hepatocellular carcinoma cells. Appl Biochem Biotechnol 172: 784-791, 2014.
276. Zhao P, Mao JM, Zhang SY, Zhou ZQ, Tan Y, and Zhang Y. Quercetin induces HepG2 cell apoptosis by inhibiting fatty acid biosynthesis. Oncol Lett 8: 765-769, 2014.
277. Zhao X, Wang Q, Yang S, Chen C, Li X, Liu J, Zou Z, and Cai D. Quercetin inhibits angiogenesis by targeting calcineurin in the xenograft model of human breast cancer. Eur J Pharmacol 781: 60-68, 2016.
278. Zheng J, Wu J, Chen J, Liu J, Lu Y, Huang C, Hu G, Wang X, and Zeng Y. Therapeutic effects of quercetin on early inflammation in hypertriglyceridemia-related acute pancreatitis and its mechanism. Pancreatology 16: 200-210, 2016.
279. Zheng Y, Scow JS, Duenes JA, and Sarr MG. Mechanisms of glucose uptake in intestinal cell lines: role of GLUT2. Surgery 151: 13-25, 2012.
280. Zhou J, Li LU, Fang LI, Xie H, Yao W, Zhou X, Xiong Z, Wang LI, Li Z, and Luo F. Quercetin reduces cyclin D1 activity and induces G1 phase arrest in HepG2 cells. Oncol Lett 12: 516-522, 2016.
281. Zhou J, Liang S, Fang L, Chen L, Tang M, Xu Y, Fu A, Yang J, and Wei Y. Quantitative proteomic analysis of HepG2 cells treated with quercetin suggests IQGAP1 involved in quercetin-induced regulation of cell proliferation and migration. OMICS 13: 93-103, 2009.
282. Ziegler K, Tumova S, Kerimi A, and Williamson G. Cellular asymmetric catalysis by UDP-glucuronosyltransferase 1A8 shows functional localization to the basolateral plasma membrane. J Biol Chem 290: 7622-7633, 2015.
283. Zucco F, Batto AF, Bises G, Chambaz J, Chiusolo A, Consalvo R, Cross H, Dal Negro G, de A, I, Fabre G, Guillou F, Hoffman S, Laplanche L, Morel E, Pincon-Raymond M, Prieto P, Turco L, Ranaldi G, Rousset M, Sambuy Y, Scarino ML, Torreilles F, and Stammati A. An inter-laboratory study to evaluate the effects of medium composition on the differentiation and barrier function of Caco-2 cell lines. Altern Lab Anim 33: 603-618, 2005.